CA Patent

CA2686267C — Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof

Assigned to Atnx Spv LLC United States · Expires 2015-10-06 · 11y expired

What this patent protects

The invention relates to compositions comprising 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)--V-benzylacetamide and its mesylate and dihydrochloride salts. More specifically, the invention provides an efficient process for the synthesis of 2-(5- < 4-(2-morpholinoethoxy)ph…

USPTO Abstract

The invention relates to compositions comprising 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)--V-benzylacetamide and its mesylate and dihydrochloride salts. More specifically, the invention provides an efficient process for the synthesis of 2-(5- < 4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-AA benzylacetainide and its mesylate and dihydrochloride salts and methods for modulating one or more components of a kinase cascade using the compositions of the invention.

Drugs covered by this patent

Patent Metadata

Patent number
CA2686267C
Jurisdiction
CA
Classification
—
Expires
2015-10-06
Drug substance claim
No
Drug product claim
No
Assignee
Atnx Spv LLC United States
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.